Medication Therapy Management Interventions in Outpatient Settings describes intervention components and implementation features for outpatient medication therapy management (MTM) interventions with comprehensive medication review, follow-up, education, and care coordination. Assesses the effectiveness of these MTM interventions on intermediate, patient-centered, or resource utilization outcomes; identifies intervention features and patient characteristics that moderate the effect of an intervention on outcomes; and assess harms associated with interventions.
On August 22, 2014, the DEA issued a final rule (79 FR 49661) in which they rescheduled hydrocodone combination products (HCPs) from schedule III to schedule II of the Controlled Substances Act as of October 6, 2014.
Project description, implementation overview, schedule and program documents for the 2014 Mercer University Student Symposium hosted by Mercer University.
The Centers for Medicare and Medicaid Services (CMS) recently released an updated guidance and standard prior authorization (PA) form for medication coverage for hospice beneficiaries. It supersedes a guidance released on March 10, 2014 (but implemented on May 1, 2014).